Cargando…

1249. Metabolomic Profile of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) in Latin-American MRSA Isolates

BACKGROUND: Vancomycin (VAN) is a first-line therapeutic option in severe infections caused by MRSA in Latin-America (LA). Development of reduced susceptibility to VAN has been associated with multiple changes in genes encoding pathways for cell wall metabolism and envelope stress responses. Neverth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castro-Cardozo, Betsy E, Cala, Monica, Espitia-Acero, Catalina, Rios, Rafael, Leon, Lizeth, Arias, Cesar A, Rincon, Sandra, Reyes, Jinnethe, Diaz, Lorena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644742/ http://dx.doi.org/10.1093/ofid/ofab466.1441

Ejemplares similares

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
por: Lai, Chih-Cheng, et al.
Publicado: (2017)

Modulating Activity of Vancomycin and Daptomycin on the Expression of Autolysis Cell-Wall Turnover and Membrane Charge Genes in hVISA and VISA Strains
por: Cafiso, Viviana, et al.
Publicado: (2012)

Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain
por: Di Gregorio, Sabrina, et al.
Publicado: (2017)

721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014)

1827. Genetic Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Associated with the Development of Reduced Susceptibility to Vancomycin from Latin America
por: Liliana Vargas Ardila, Monica, et al.
Publicado: (2019)

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study
por: Martirosov, Dmitriy M., et al.
Publicado: (2017)

1442. Acquisition and Transferability Mechanisms of Mercury Resistance Genes in Latin-American Staphylococcus aureus Strains
por: Ortega-Recalde, Oscar, et al.
Publicado: (2020)

557. Impact of Heavy Metal Exposure in the Transcriptional Response of Methicillin--Resistant Staphylococcus aureus (MRSA)-USA300 Latin-American Variant (USA300-LV)
por: Echeverri, Aura M, et al.
Publicado: (2019)

1221. Genetic Characteristics of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Belonging to Clonal Complex 5 (CC5) in Latin-America
por: Reyes, Jinnethe, et al.
Publicado: (2018)

Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure
por: Rios, Rafael, et al.
Publicado: (2020)

1214. High Frequency of Genes Encoding Resistance to Heavy Metals in Methicillin-Resistant Staphylococcus aureus (MRSA) Endemic Lineages From South America
por: Diaz, Lorena, et al.
Publicado: (2018)

Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Su, Michelle, et al.
Publicado: (2021)

Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)

Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA)
por: McCallin, Shawna, et al.
Publicado: (2022)

728. Genomic Characterization of Burkholderia pseudomallei Isolates in Colombia
por: Espitia-Acero, Catalina, et al.
Publicado: (2021)

Community-Associated MRSA Infection in Remote Amazon Basin Area, Peru
por: García, Coralith, et al.
Publicado: (2016)

Detection of Staphylococcus aureus with an intermediate profile to vancomycin (VISA) isolate from Santa Maria, RS
por: Marques, Jaciane Baggiotto, et al.
Publicado: (2013)

556. Phylogenomic Epidemiology of Methicillin-Resistant Staphylococcus aureus (MRSA) Chilean-Cordobes Clone in Latin America
por: Martínez, Jose R W, et al.
Publicado: (2019)

Balancing the Virulence and Antimicrobial Resistance in VISA DAP-R CA-MRSA Superbug
por: Salemi, Rossella, et al.
Publicado: (2022)

Aortic Root Abscess with Aorta to Right Atrium Fistula due to Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Hankinson, Stephen J., et al.
Publicado: (2019)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Intermediate-Type Vancomycin Resistance (VISA) in Genetically-Distinct Staphylococcus aureus Isolates Is Linked to Specific, Reversible Metabolic Alterations
por: Alexander, Elizabeth L., et al.
Publicado: (2014)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
por: Graber, Christopher J., et al.
Publicado: (2007)

American visa
Publicado: (2005)

Vancomycin resistance among MRSA
por: Kumar, V. Anil
Publicado: (2012)

Dynamics of the MRSA Population in a Chilean Hospital: a Phylogenomic Analysis (2000–2016)
por: Martínez, José R. W., et al.
Publicado: (2023)

Alignment of the VISA undulator
por: Ruland, R E, et al.
Publicado: (1999)

Mechanical Design of the VISA Undulator
por: Libkind, M, et al.
Publicado: (1999)

Measurement and Optimization of the VISA Undulator
por: Rakowsky, G, et al.
Publicado: (1999)

1453. PBP2, PBP2a and PBP4 Clone-specific Polymorphisms are not Associated to Ceftaroline (CPT) Susceptibility in Chilean Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Spencer, Maria de los Angeles, et al.
Publicado: (2020)

Unveiling the Mechanism of Action of 7α-acetoxy-6β-hydroxyroyleanone on an MRSA/VISA Strain: Membrane and Cell Wall Interactions
por: Pereira, Filipe, et al.
Publicado: (2020)

1249. Emergence of Diverse Carbapenem-Resistant Enterobacteriaceae (CRE) in the Dominican Republic
por: Fermin, Rita Rojas, et al.
Publicado: (2018)

Correction to Lancet Glob Health 2023; 11: e1249–59
Publicado: (2023)

Photon Beam Diagnostics for VISA FEL-
por: Murokh, A, et al.
Publicado: (1999)

The Global Evolution of Travel Visa Regimes
por: Czaika, Mathias, et al.
Publicado: (2018)

2063. Extracellular Release of β-Lactamase Is Responsible for the Cefazolin Inoculum Effect (CzIE) in Methicillin-Susceptible Staphylococcus aureus
por: Carvajal, Lina P, et al.
Publicado: (2018)

FANCJ/BACH1 Acetylation at Lysine 1249 Regulates the DNA Damage Response
por: Xie, Jenny, et al.
Publicado: (2012)

1249. Stealth Stewardship: Compliance with Antimicrobial Restriction Processes at an Academic Medical Center
por: Kim, Jihye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g8lpotue70qggqf4sn9akil546